The research outsourcing facility has been considered a recognition of the growing strength of India in pharmaceuticals.
According to the release stating the latest update, the USP site in India would help promote the availability of good-quality therapeutic products globally. USP-India will provide USP's pharmacopeial services to customers in India and surrounding countries.
The site would also include a state-of-the-art laboratory and experienced Indian scientists in the standards-setting activities of USP.
USP sets quality benchmarks for medicines, dietary supplements and other healthcare products. It also works with healthcare providers to help them attain USP's standards which are recognised not only in the US but elsewhere too.
The location of the USP lab in Hyderabad is expected to boost contract research outsourcing of the state and facilitate certification of the drugs manufactured in the state which, is a big supplier of bulk drugs to US.
The USP-India site will allow USP to work more closely with Indian and regional constituencies, including the Indian Pharmacopoeia and Indian pharmaceutical manufacturers, to promote the manufacture of good-quality, safe and effective medicines for the US market and elsewhere, the release added.
USP has also created an Indian Advisory Group (IAG) to assist the organisation in addressing national and regional issues.
